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ABSTRACT 
The aim of this study was to evaluate clinical, microbiological, and 
immunological patterns of dental implants placed in healthy, partially edentulous, patients 
(HH), and those with a history of aggressive (HGAgP) or chronic periodontitis (HGCP), 
considering the null hypothesis that there are no differences between groups. This 
prospective, parallel, controlled trial enrolled 45 patients (HGAgP, n = 13; HGCP, n = 18; 
HH, n = 14) followed up from implant insertion until six months after implant loading. 
Plaque index (PI), bleeding on probing (BOP), probing depth (PD), relative clinical 
attachment level (rCAL), gingival margin position (rGMP), implant stability (IS), and 
radiographic marginal bone resorption (RMBR) around implants were evaluated. 
Porphyromonas gingivalis (Pg), Aggregatibacter actinomycetemcomitans (Aa), and 
Tannerella forsythia (Tf) levels were evaluated by real-time PCR. Also, IL-1β, TNFα, IL-6, 
IL-8, IFNγ, GM-CSF, IL-4, IL-10, RANKL, and OPG levels were evaluated with the 
LUMINEX/MAGPIX
®
 platform. No inter-group differences were observed around dental 
implants when the clinical parameters (PI, BOP, PD, rCAL, rGMP, IS, and RMBR) (p > 
0.05) were considered at any evaluation period. At the first month after implant loading, 
those in the HGAgP group presented a higher level of Aa (p < 0.05). Six months after 
implant loading, those in the HH group presented a lower level of Pg (p < 0.05). The 
immunologic evaluation showed higher values of OPG in those in the HH group at implant 
loading, and a higher IL-4 level in those in the HH group six months after implant loading. 
It can be concluded that, after six months of implant loading, despite some micro and 
immunological differences, there are no clinical differences or additional RMBR around 
implants placed in patients with a history of periodontal disease.  
Key-words: aggressive periodontitis, dental implants, bone resorption. 
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RESUMO 
O objetivo deste estudo foi avaliar os parâmetros clínicos, imunoenzimáticos e 
microbiológicos de implantes dentais de estágio único instalados em pacientes com 
histórico de periodontite agressiva, periodontite crônica e saúde, considerando a hipótese de 
nulidade de que não existem diferenças entre os grupos. Foram selecionados pacientes que 
apresentaram histórico de periodontite agressiva generalizada (PAG) e periodontite crônica 
generalizada (PCG) com indicação de reabilitação protética implanto suportada. Os 
pacientes com necessidade de reabilitação unitária foram divididos em 3 grupos:  Grupo 
PAG (n = 13): pacientes apresentando histórico de periodontite agressiva generalizada; 
Grupo PCG (n = 18):  pacientes com histórico de PCG; e Grupo Controle (n = 14): 
pacientes sem histórico de periodontite. Todos os implantes foram instalados em estágio 
único e, após 3 meses, receberam reabilitação com próteses metalocerâmicas unitárias 
parafusadas. Profundidade de sondagem, nível clínico de inserção relativo e posição da 
margem gengival relativo foram avaliados nos implantes no momento da instalação da 
prótese e 1, 3 e 6 meses após o carregamento. Avaliação radiográfica foi feita no momento 
7 dias após a cirurgia, na instalação da prótese e 6 meses após o carregamento protético. 
Avaliação microbiológica foi realizada imediatamente após a instalação da prótese, 1, 3 e 6 
meses após, por meio de PCR real time, determinando a quantidade dos microrganismos A. 
actinomycetemcomitans, P. gingivalis e, T. forsythia Avaliação imunológica foi realizada 
utilizando o sistema LUMINEX/MAGPIX
®
 com amostras de fluido periimplantar coletado 
aos 15 dias após a cirurgia, imediatamente após a instalação da prótese e 6 meses após o 
carregamento protético, avaliando as concentrações de IL-1β, IL-4, IL-6, IL-8, IL-10, 
TNFα, INFγ e GM-CSF, além de marcadores de osteogênese e osteoclasia (OPG e 
RANKL). Não foram observadas diferenças entre os perfis de pacientes quanto aos 
parâmetros clínicos e radiográficos ao redor dos implantes em nenhum dos períodos de 
avaliação. No primeiro mês após a instalação das próteses verificou-se maior concentração 
de Aa (p < 0,05) no grupo PAG. Seis meses após a instalação das próteses o grupo Controle 
apresentou menores concentrações de Pg (p < 0,05). A avaliação dos marcadores de 
osteogênese/osteoclasia indicou alta concentração de OPG no grupo controle no momento 
 x 
da instalação da prótese. Ainda neste grupo, alta concentração de IL-4 foi observada 6 
meses após o carregamento dos implantes. Dentro das limitações deste estudo, pode ser 
concluído que 6 meses após a instalação das próteses, não há diferenças clínicas nem 
adicional reabsorção óssea em implantes dentários instalados em pacientes com histórico de 
doença periodontal.  
Palavras-chave: periodontite agressiva, implantes dentários, reabsorção óssea. 
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1 INTRODUCTION/INTRODUÇÃO 
 
Oral rehabilitation with dental implants is an important approach for the re-
establishment of esthetics and function in partially and totally edentulous patients 
(Branemark et al., 1977; Buser et al., 1997).  Recent systematic reviews have shown good 
survival and success rates with oral implant rehabilitation (Pjetursson et al., 2004; Ong et 
al., 2008). However, some studies have demonstrated that patients presenting a history of 
periodontal disease showed a higher risk of implant failure and greater marginal bone loss 
than did periodontal healthy individuals (Safii et al., 2010; Donos et al., 2012). Implant 
survival rates in patients with a history of periodontal disease have ranged from 79.22% to 
100% (Hardt et al., 2002; Karoussis et al., 2003; Evian et al., 2004; Roos-Jansaker et al., 
2006; Kim & Sung, 2012), while the success rates ranged from 33% to 100% (Karoussis et 
al., 2003; Mengel & Flores-de-Jacoby, 2005; Swierkot et al., 2012). Most studies have 
attributed these lower rates to higher susceptibility to peri-implant mucositis and peri-
implantitis in patients with a history of periodontal disease (Donos et al., 2012). 
The higher risk of peri-implant infection in individuals with periodontitis could 
be explained by microbiological linkage. Studies have demonstrated the association of 
Aggregactibacter actinomycetemcomitans, Porphyromonas gingivalis, Treponema 
denticola, Tannerella forsythia, and Prevotella intermedia with peri-implant diseases 
(Casado et al., 2011; Cortelli et al., 2013). At the same time, it has been demonstrated that, 
even after tooth loss, key periodontal pathogens remain, colonizing the oral cavity 
(Fernandes et al., 2010). Thus, adjacent periodontal sites, the tongue, tonsils, and saliva can 
be reservoirs of pathogenic microorganisms (Quirynen et al., 2005; Aoki et al., 2012; Ito et 
al., 2013) and can aggressively colonize peri-implant sites. However, the presence of these 
bacteria per se is not a determining factor for disease onset, since pathogens can also be 
found in healthy peri-implant conditions (Casado et al., 2011; Cortelli et al., 2013). Thus, in 
addition to the bacterial load around implants, host susceptibility by an altered 
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inflammatory response could influence the homeostasis of dental implants inserted into 
patients with periodontitis. 
Previous studies have indicated that the peri-implant gingiva may be 
characterized by a high pro-inflammatory state, even under apparent homeostatic 
conditions (clinically healthy tissues) (Nowzari et al., 2008). The presence of cytokines like 
IL-1β, TNFα, and IL-8 can be a predictor of peri-implant destruction (Petkovic et al., 
2010). Thus, an analysis of inflammatory factors is important when individuals at higher 
risk for periodontitis are considered for implant therapy. This becomes even more 
important in the consideration of aggressive periodontitis, which presents an imbalance 
between pro- and anti-inflammatory cytokines (Teles et al., 2010) and could explain the 
most prevalent mucositis and peri-implantitis assessed in this population (Swierkot et al., 
2012).  
In this context, in view of the few studies in the literature that have investigated 
this condition, the aim of this study was to evaluate clinical, microbiological, and 
immunological patterns of dental implants placed in healthy, partially edentulous, patients, 
and those with a history of aggressive or chronic periodontitis, considering the null 
hypothesis that there are no differences between groups. 
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2 LITERATURE REVIEW/REVISÃO DA LITERATURA 
 
Survival, success and implant bone loss in patients with history of periodontal disease 
Osseointegrated implants are widely used to treat partially and totally 
edentulous patients. This kind of approach has presented high levels of success and survival 
rates and has been indicated as a predictable treatment strategy. Despite its predictability, 
some risk factors can negatively influence the results of implant therapy, leading to implant 
loss or increasing the occurrence of implant complications, such as periimplant infections. 
The history of periodontal disease has been reported as a risk factor for implant 
dentistry. Recent meta-analysis and systematic reviews have highlighted the hypothesis that 
patients with history of periodontal disease present higher chance to pursuit implant loss, 
periimplantitis and implant-bone loss, than healthy patients (Safii et al., 2010; Kim et al., 
2012; Sgolastra et al., 2013). Nonetheless, this is not a consensus among all the studies in 
the literature.  
Mengel and Flores-de-Jacoby (2005) developed a prospective longitudinal 
study following 150 implants placed in 39 patients. Clinical and radiographic comparisons 
were made between patients treated for generalized aggressive periodontitis (GAP), 
generalized chronic periodontitis (GCP) and healthy patients. After 3 years, the implant 
success rates recorded were 100% in the periodontally healthy (PH) and GCP patients, and 
95.7% in the maxilla and 100% in the mandible of GAP patients. Probing depth (PD) and 
attachment level (AL) around implants were 3.17 mm and 4.30 mm in GAP group, 2.69 
mm and 4.57 mm in GCP group and 3.28 and 4.03 mm in periodontally healthy patients, 
without difference between groups. Considering radiographic bone loss (BL), after 3 years 
GAP, GCP and healthy patients presented 1.14 mm, 0.86 mm and 0.70 mm of BL 
respectively. 
Ferreira et al. (2006) performed a study which aim was to verify the prevalence 
of peri-implant disease and to analyze possible risk variables associated with peri-implant 
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diseases. After clinical and radiographic evaluations of 212 partially edentulous subjects, 
the authors performed a multinomial regression analysis that indicated the presence of 
periodontitis as one of the variables associated with increased risk of peri-implantitis. In 
this study the prevalence of peri-implant mucositis and peri-implantitis were 64.6% and 
8.9%, respectively. 
Mengel et al. (2007) developed another prospective 10-year clinical and 
radiographic study of partially edentulous subjects treated for GAP (5 subjects) comparing 
their implants with those of PH patients (5 subjects). The peri-implant PD was similar in 
the two groups and remained less than 5 mm throughout the follow up. Attachment loss 
was higher in GAP group (2.4 mm). The implant success rate differed between groups 
(83.33% for GAP and 100% for PH). The mean of peri-implant BL at 10-year follow up 
was 3.37 mm for GAP group and 1.24 for PH group. The authors concluded that GAP 
patients can be successfully rehabilitated with osseointegrated implants, however, it can be 
expected greater bone and attachment loss at implants placed in these kind of patients. 
Gatti et al. (2008) evaluated the outcome of dental implants placed in partially 
edentulous patients with a history of severe periodontitis (26 patients and 129 implants), 
moderate periodontitis (7 patients and 26 implants) and no history of periodontitis (29 
patients and 72 implants). After 5 years, patients affected by severe and moderate 
periodontitis lost on average twice the amount of peri-implant bone compared with the 
healthy patients (2.6 mm versus 1.2 mm). Thus, concluded that patients with history of 
periodontitis lose more peri-implant bone than PH patients. 
De Boever et al. (2009) followed 16 GAP patients, 68 GCP patients and 110 
PH patients in a prospective clinical trial during no more than 6 years. In spite of the 
presence of confounding factors like smoking habits and bone regeneration procedures, the 
authors observed survival rates of 84.8%, 96% and 97% in GAP, GCP and PH patients, 
respectively. Also, difference between groups was found at peri-implant bone loss 
evaluation. They reported that marginal bone loss per year was 0.12 and 0.08 mm in GCP 
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and PH patients and 0.17 mm in GAP patients. Once more, generalized aggressive 
periodontitis patients presented lower results of implant therapy. 
Koldsland et al. (2009) performed a study to investigate the prevalence of 
implant loss and the factors associated with the outcome of dental implants. With an 
average of 8.4 years (range, 1.1 to 16 years) after oral rehabilitation using dental implants, 
109 patients (372 implants) were clinically and radiographically evaluated. Eighteen 
implants (4.8%) were lost in 10 subjects. Eleven implants were lost before loading, three 
were lost during the first 5 years after loading, and four were lost 5 to 10 years after 
loading. The loss of implants was significantly associated with a history of smoking and 
periodontitis (p < 0.05) and the survival rate at subject and implant level were 90.8% and 
95.2%. 
Roccuzzo et al. (2010) aimed to compare the long-term outcomes of implants 
placed in periodontally compromised patients and in PH patients. At 10 years after oral 
rehabilitation with dental implants, clinical measurements and radiographic bone changes 
were recorded. During the period of observation, 18 implants were removed because of 
biological complications. The implant survival rate was 96.6% (PH patients), 92.8% 
(moderate periodontitis patients) and 90% (severe periodontitis patients). The mean bone 
loss was 0.75 mm in PH patients, 1.14 mm in moderate periodontitis patients, and 0.98 mm 
in severe periodontitis patients, but without difference between groups. Patients with severe 
periodontitis experimented more sites presenting bone loss ≥ 3mm than PH patients. The 
authors concluded that patients with history of periodontitis presented a lower survival rate 
and a higher number of sites with peri-implant bone loss. 
Levin et al. (2011) aimed to evaluate the long-term survival rate of dental 
implants according to the patient’s periodontal status. The prospective study evaluated 736 
patients and 2336 dental implants during an average of 54.4 months. The cumulative 
survival rates at 108 months were 96%, 95% and 88% for, healthy, moderate chronic and 
severe chronic periodontal patients, respectively.  Severe chronic disease turned out to be a 
significant risk factor for implant failure after 50 months of follow up (Hazard ratio = 8.06; 
 6 
p < 0.01). Thus, periodontal status was considered a significant risk factor for late implant 
failure. 
Swierkot et al. (2012) developed a prospective study following patients during 
5 to 16 years to investigate the prevalence of mucositis, peri-implantitis, implant success 
and implant survival rates in partially edentulous subjects.  Thirty-five GAP patients and 18 
PH patients were rehabilitated with osseointegrated implants and presented implant survival 
rate of 100% in PH patients and 96% in GAP patients.  In spite of that, the implant success 
rate was 33% in GAP and 50% in PH group. In GAP patients, mucositis was presented in 
56% and peri-implantitis in 26% of the implants. In periodontally healthy individuals, 40% 
of the implants showed mucositis and 10% peri-implantitis. So, GAgP patients had a five 
times greater risk of implant failure, a three times greater risk of mucositis, and a 14 times 
greater risk of peri-implantitis.  
Jiang et al. (2013) evaluated the efficacy of implant supported dental 
restorations in 30 patients with (149 implants) and 30 patients without (127 implants) 
periodontal disease within 2 years of completing the treatment. There was no difference in 
success rate between groups (95.97% for periodontitis group and 97.60% for healthy 
group). In spite of that, modified plaque index and modified sulcus bleeding index were 
positively correlated with chronic periodontal disease. 
Casado et al. (2013) developed a study in Brazil aiming to assess if patients 
with history of chronic periodontitis were more susceptible to peri-implant disease then 
those without history of periodontitis. The authors evaluated 215 patients with 754 dental 
implants. Patients were divided into 2 groups according to the peri-implant status: control 
group (129 patients without peri-implant disease) and test group (86 patients with peri-
implant disorders). There was a highly significant correlation between chronic periodontitis 
history and peri-implant disease (p < 0.0001). Patients with periodontitis had 4 times more 
chance of developing peri-implant diseases than patients with healthy periodontal tissues. 
Also, periodontitis patients showed higher bone loss around implant (p = 0.004) when 
compared with patients without periodontitis. 
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Marrone et al. (2013) evaluated a Belgian population to verify the frequency of 
mucositis and peri-implantitis in patients with dental implants with at least 5 years of 
function. One hundred and three patients (38 males/65 females) with a total of 266 implants 
were examined and the mean time of implants in function was 8.5 years (±3.2). Prevalences 
of mucositis and peri-implantitis at patient's level were respectively 31% and 37%. They 
were 38% and 23% at the implant's level. Subjects with active periodontitis (OR = 1.98) 
were found to be prone to peri-implantitis. Consequently, patients with such characteristic 
should be informed before implant placement and frequently re-called for maintenance 
visits. 
Roccuzzo et al. (2013) evaluated, clinically and radiographically, 123 partially 
edentulous patients 10 years after oral rehabilitation with dental implants. No difference 
between periodontitis and healthy groups occurred in implant survival rate. The percentage 
of implants with at least one site presenting probing depth > 5 mm was higher in 
periodontitis patients (9.4% in moderate and 10.8% in severe periodontitis patients) than in 
healthy patients (0%). 
Trying to explain the issue about crestal bone changes around teeth and 
implants, Rasperini et al. (2013) developed a 10-year radiographic evaluation of 120 oral 
rehabilitations (60 patients with history of periodontal disease and 60 PH patients). At 10 
years post therapy, the survival rate ranged from 80% to 95% for subgroups for implants in 
both groups. Greater bone loss was observed in smoker patients with history of periodontal 
disease (average 3.01 mm). 
Continuing the marginal bone loss investigation, Galindo-Moreno et al. (2014) 
analyzed marginal bone loss rates around implants. Five hundred and eight implants were 
placed in 208 patients. Data were gathered on age, gender, bone stratum, prosthetic 
connection, smoke and alcohol habits, and previous periodontitis. The results showed that 
most of the implants with higher bone loss were found in a low portion of the patients, 
similar to the pattern observed for periodontitis. Nonetheless, a history of periodontitis was 
not significantly related to the marginal bone loss in this study. 
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In spite of this controversial results showed in the literature, recent systematic 
reviews and meta-analysis have pointed the history of periodontal disease as risk factor for 
dental implant therapy. Safii et al. (2010) purposed to evaluate the risk for marginal bone 
loss around implants and implant failure in subjects with a history of periodontitis 
compared with periodontally healthy subjects in studies with a minimum 3-year follow-up. 
The odds ratio for implant survival was significantly in favor of PH patients (3.02, 95% CI 
1.12-8.15). A random effects model showed more marginal bone loss in periodontitis 
subjects compared with periodontally healthy subjects (standard mean difference 0.61, 95% 
CI 0.14-1.09). So, a moderate level of evidence indicates that periodontitis subjects were at 
significantly higher risk for implant failure and greater marginal bone loss than PH 
subjects. 
With the purpose of analyzing the current literature and to assess outcomes of 
implant treatment in GAP patients, Kim et al. (2012) developed a systematic review 
divided the studies in short term (< 5 years) and long term studies (≥ 5 years). Seven 
prospective studies were selected, including four short-term and three long-term studies. 
The survival rates of the superstructures were generally high in patients with GAP, i.e. 95.9 
- 100%. Marginal bone loss around implant in patients with GAP as compared to implants 
in patients with chronic periodontitis or periodontally healthy patients was not significantly 
greater in short term studies but was significantly greater in long-term studies. In short term 
studies, the survival rates of implants were between 97.4% and 100% in patients with GAP-
associated tooth loss, except in one study. The survival rates of implants were between 
83.3% and 96% in patients with GAP in long-term studies. 
Sgolastra et al. (2013) developed a systematic review and meta-analysis to 
assess the role of periodontal disease as a risk factor for implant loss, peri-implantitis and 
implant bone loss. Meta-analysis revealed that a higher and significant risk for implant loss 
was present in patients affected by periodontal disease (RR: 1.89, 95% CI: 1.35 – 2.66, p = 
0.0002), but the risk was increased for patients with aggressive periodontitis (RR: 4.04, 
95% CI: 1.81 – 8.98, p = 0.0006). A higher and significant implant bone loss was presented 
in patients with periodontal disease, when compared with PH patients (0.44 mm, 95% CI: 
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0.19 – 0.69, p = 0.0006). Periodontally compromised patients showed an increased risk for 
peri-implantitis, when compared with PH patients (RR: 2.21, 95% CI: 1.42 – 3.43 p = 
0.0004). In conclusion, there is a strong evidence suggesting periodontitis as a risk factor 
for implant loss, moderate evidence revealed that periodontitis is a risk factor for peri-
implantitis and that patients with periodontitis have higher implant bone loss. 
Finally, Faggion & Giannakopoulos (2013) critically revised the systematic 
reviews that evaluated the effect of a history of periodontitis on dental implant loss. The 
authors concluded that the methodological quality of the sample of systematic reviews was 
extremely heterogeneous. In spite of that, most systematic reviews report a positive 
association between history of periodontitis and risk of implant failure. 
 
Microbiological aspects of implants  
The studies have shown that peri-implant diseases have common characteristics 
with periodontal diseases. These are: inflammation process involving biofilm and host 
susceptibility. So the presence of specific bacteria could influence the outcomes of implant 
rehabilitation. Since bacteria colonization begins immediately after implant exposure in 
oral environment, saliva, tonsils, mucosa, tongue and persistent periodontal pockets are 
considered sources for peri-implant sulcus. Therefore, patients with history of periodontitis 
could have pathogenic bacteria colonizing this structure.   
Apse et al. (1989) investigated the soft tissues adjacent to osseointegrated 
implants using clinical, biochemical and microbiological methods. The subgingival 
bacterial flora was examined and cultured. Few differences were observed between 
implants and teeth in partially edentulous patients, indicating that crevices around teeth 
may act as reservoirs of bacteria, which can colonize implant sites. A higher percentage of 
black-pigmented bacteria and wet spreaders (Capnocytophaga) was noticed at partially 
edentulous implant sites when compared with edentulous implant sites, perhaps, reflecting 
the lower number of periodontal pathogens present in edentulous mouths. Overall, the 
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characteristics of implant sulci appear to be similar to periodontal sulci with respect of 
crevicular fluid flow and microflora. 
Quirynen & Listgarten (1990) evaluated the subgingival plaque around 
implants by means of differential phase-contrast microscopy. In 24 partially edentulous 
patients (with implants and teeth in the same jaw), no significant difference in the 
distribution of bacterial morphotypes could be found between implants and natural teeth. 
However, when the plaque composition on the implants of fully edentulous patients was 
compared with those of teeth or implants of partially edentulous patients (with teeth and 
implants in the same and/or opposite jaw), significant differences appeared. In fully 
edentulous patients, more coccoid cells (71.3%) and significant fewer motile rods (0.4%) 
and spirochetes (0.0%) were found around the implants. The results suggest that teeth may 
serve as a reservoir for the bacterial colonization of titanium implants in the same mouth. 
Mombelli et al. (1995) evaluated subgingival microbial samples from deepest 
residual pockets of patients with a history of periodontitis before the implant insertion, and 
samples of peri-implant sulcus in the same patients 3 and 6 months after implant insertion. 
The samples were cultured using continuous anaerobic techniques. The authors found 
presence of Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium and 
spirochetes around implants in those patients that previously presented these kinds of 
bacteria in the residual pockets. So it suggested that bacterial colonization could occur from 
residual pockets to peri-implant sulcus. 
Papaioannou et al. (1996) examined the relation between the subgingival flora 
around implants and their periodontal parameters in 279 patients (561 implants). The 
impact of the intraoral exposure time on the microbial composition around the implants was 
cross-sectionally examined, with the same group of patients, but only tendencies could be 
detected by the latter, and no concrete conclusions could be drawn. For partially edentulous 
patients, there was a tendency for increased proportions of spirochetes and motile 
organisms the longer the intraoral exposure time. These observations emphasize the 
importance of the periodontal health of the remaining teeth (as a reservoir of pathogenic 
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microorganisms) in partial edentulous patients rehabilitated by means of implants and 
indicate the importance of shallow pockets around implants. 
Papaiouanou et al. (1996) examined, in partially edentulous patients with severe 
periodontitis, whether pockets around teeth and implants harbored a comparable micro-
flora. In 6 patients (3 with refractory periodontitis and 3 with advanced chronic adult 
periodontitis), plaque samples were taken from a deep and shallow pocket around both 
teeth and implants for differential phase contrast microscopy and DNA probe analysis. The 
results showed important differences in the subgingival flora between the 2 disease groups, 
as well as between deep and shallow pockets, around both implants and teeth. On the other 
hand, when pockets around teeth and implants with equal depths were compared a striking 
similarity was observed in the microbial composition. These observations confirm the 
hypothesis that pockets around teeth act as a reservoir and highlight the importance of 
periodontal health when oral implants are planned. 
Quyrinen et al. (1996) found that the subgingival flora around the implants 
harbored more spirochetes and motile rods when teeth were present in the same jaw (p < 
0.05) and/or when the pockets around them harbored a pathogenic flora (p < 0.05). They 
also investigated the impact of periodontitis around the remaining teeth and the impact of 
probing depth around the implants on the composition of the peri-implant subgingival flora. 
The samples from deep pockets (≥ 4 mm) around implants showed significant increase in 
the total proportion of spirochetes and motile organisms when compared to samples from 
healthy subjects (1.2%) or in chronic periodontitis patients (21.0%), or in patients suffering 
from refractory periodontitis (31.5%). The findings of this study confirmed the 
transmission of microorganisms from teeth to implants. 
Gouvoussis et al. (1997) investigated 25 tooth and implant sites for the presence 
of putative periodontopathic organisms, using specific DNA probes for Actinobacillus 
actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Eikenella 
corrodens, Fusobacterium nucleatum, Treponema denticola, and Campylobacter recta. 
Five of nine patients showed a likelihood of transmission from tooth to implant sites. These 
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patients also showed a high number of putative periodontopathic organisms present in the 
tested tooth sites. A significant risk was found for transmitting putative periodontopathic 
organisms from periodontitis sites to implant sites in the same mouth.  
Lee et al. (1999) evaluated implant colonization by species in a newly described 
red complex of periodontal pathogens, Porphyromonas gingivalis and Bacteroides 
forsythus. Forty-three partially edentulous subjects with successfully osseointegrated dental 
implants were examined and the microbiota from peri-implant sites were analyzed using 
DNA probes in a checkerboard assay. Implants were mainly colonized by oral streptococci, 
capnocytophagae, Veillonella parvula, Peptostreptococcus micros, and Fusobacterium 
nucleatum. The periodontal species, P. gingivalis, B. forsythus, Prevotella intermedia, 
Prevotella nigrescens, and Campylobacter rectus were detected in few subjects. Microbial 
complexity increased as loading time increased, but colonization by periodontal pathogens, 
including red complex species, was higher in subjects with previous periodontal disease.  
Sbordone et al. (1999) purposed to determine the clinical status and the 
composition of the subgingival microbiota of dental implants and natural teeth in patients 
with a history of periodontitis. The authors evaluated 42 implants, in 25 subjects with 
history of moderate periodontal disease, during 3 years. Probing depth and clinical 
attachment level measurements of peri-implant sites did not show any statistically 
significant difference. There was no difference detected in the subgingival microbiota, 
culturally identified at peri-implant and periodontal sites for the duration of the study. In 
conclusion, implants were colonized by the indigenous periodontal microbiota and were 
well maintained in patients with a history of periodontitis. No significant association 
between progressing or non-progressing periodontal or peri-implant sampled sites in terms 
of loss of attachment and infection with at least one of the searched periodontal pathogens 
was found, suggesting that the presence of putative periodontopathogens at peri-implant 
and periodontal sites may not be associated with future attachment loss or implant failure. 
Sumida et al. (2002) examined colonization by periodontopathic bacteria and 
their transmission from periodontal pockets to peri-implant sulcus. Samples were collected 
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from 105 sites in 15 patients and the transmission of periodontopathic bacteria from 
periodontal sites of natural teeth to the implant sulcus was analyzed by pulsed field gel 
electrophoresis (PFGE). The PCR detection rates of Porphyromonas gingivalis, Prevotella 
intermedia, Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Treponema 
denticola were 80.0%, 53.3%, 46.7%, 60.0% and 40.0%, respectively. Colonizations by P. 
gingivalis and A. actinomycetemcomitans were statistically correlated with periodontal 
pockets and implant sulcus regions (p < .01). These analyses indicated that there appeared 
to be transmission of P. gingivalis and P. intermedia from the periodontal pocket to the 
peri-implant region. 
Quirynen et al. (2005) evaluated the early colonization of ‘pristine’ pockets 
created during implant surgery in 16 partially edentulous patients. Four subgingival plaque 
samples were taken from shallow and medium pockets around implants 1, 2 and 4 weeks 
after abutment connection. Checkerboard DNA-DNA hybridization and culture data 
revealed the development of a complex microbiota, including species from red complex, in 
the ‘pristine’ pockets within 1 week. 
Quirynen et al. (2006) followed the colonization of 'pristine' sulci created in 42 
partially edentulous patients during implant surgery (e.g. abutment connection). Per patient, 
four subgingival plaque samples were taken from shallow and medium pockets around 
implants (test sites), and teeth within the same quadrant (undisturbed microbiota as control 
sites), 1, 2, 4, 13, 26 and 78 weeks after abutment connection, respectively. Checkerboard 
DNA-DNA hybridization and real-time PCR revealed a complex microbiota (including 
several pathogenic species) in the peri-implant pockets within 2 weeks after abutment 
connection. After 7 days, the detection frequency for most species (including the bacteria 
associated with periodontitis) was already nearly identical in samples from the fresh peri-
implant pockets (5% and 20% of the microbiota belonging to red and orange complex, 
respectively) when compared with samples from the reference teeth. Afterwards (between 
weeks 2 and 13), the number of bacteria in peri-implant pockets only slightly increased (+/-
0.1 log value), with minor changes in the relative proportions of bacteria associated with 
periodontitis (8% and 33% of the microbiota belonging to red and orange complex, 
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respectively). Although small differences were seen between teeth and implants at week 2 
with cultural techniques, a striking similarity in subgingival microbiota was found with this 
technique from month 3 on. So, this study indicated that the initial colonization of peri-
implant pockets with bacteria associated with periodontitis occurs within 2 weeks. 
De Boever & De Boever (2006) evaluated the early colonization of non-
submerged implants over a 6-month period in partially edentulous patients treated for 
advanced aggressive periodontal disease. In 22 patients, 68 non-submerged dental implants 
were installed. Using DNA-probes, the presence and concentration of five periodontal 
pathogens (Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella 
intermedia, Tannerella forsythensis and Treponema denticola) were determined in the five 
deepest pockets of the rest dentition pre-operatively and after 6 months as well as five 
places around each implant 10 days, 1 month, 3 months and 6 months after surgery. In each 
patient, a test to determine the genotype interleukin-1 (IL-1) was performed. After 6 
months, no difference in microbial composition compared with baseline was found around 
the teeth in five patients. Ten days after surgery, three patients had a complete similar 
bacterial composition between teeth and implants. In 14 patients, the composition was 
fairly similar, while large differences in composition and concentration occurred in five 
patients. This microbiota around the implants remained almost unchanged over a 6-month 
period and did not hamper the clinical and radiographic osseointegration and did not lead to 
peri-implantitis, mucositis or initiation of bone destruction. 
Mombelli & Décaillet (2011) conducted a literature review and described the 
microbiota associated with peri-implant disease. In most studies bacterial samples were 
obtained by methods that destroyed the three-dimensional structure of the biofilm. The 
samples therefore describe mixtures of bacteria from unspecified districts of biofilm 
associated with peri-implant diseases. Analyses of such samples with various methods 
indicate that peri-implant disease maybe viewed as a mixed anaerobic infection. In most 
cases the composition of the flora is similar to the subgingival flora of chronic periodontitis 
that is dominated by gram-negative bacteria.  
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Lachmann et al. (2012) provided a clinical and microbiological investigation in 
74 subjects. Signs of a serious peri-implantitis condition were not encountered. However, a 
high prevalence of moderate plaque and bleeding on probing (60% and 78%) and PCR 
proof of periodonto-pathogenic bacteria (43% positive for one or more target species) were 
apparent. The authors pointed that a considerable number of individuals exhibited peri-
implant findings that would require anti-infective treatment. 
Cortelli et al. (2013) evaluated the presence of Porphyromonas gingivalis, 
Tannerella forsythia, Campylobacter rectus, Prevotella intermedia, Treponema denticola 
and Aggregatibacter actinomycetemcomitans in peri-implant tissues presenting health, 
mucositis and peri-implantitis. Using DNA Checkboarding the authors worked with the 
frequency of presence of each bacteria. Except for P. intermedia, bacterial frequency was 
higher in peri-implantitis than in health. The frequency of P. gingivalis and red complex 
species were higher in peri-implantitis than in mucositis. 
Dierens et al. (2013) investigated the microbiota around single implants after 16 
to 22 years. Samples were analyzed by DNA-DNA hybridization including 40 species. 
Tannerella forsythia showed the highest concentration around implants and 
Porphyromonas gingivalis, Prevotella intermedia, Parvimonas micra and Treponema 
denticola were also found around implants. Total DNA count was correlated to 
interproximal bleeding index (r = 0.409) and interproximal probing depth (r = 0.307). No 
correlations were present with plaque index or radiographic bone level. In spite of the 
presence of pathogenic bacteria, the majority of implants presented healthy peri-implant 
tissues without bone loss. 
Ito et al. (2013) purposed to investigate whether the periodontal pathogen levels 
in saliva were correlated with the periodontal status of patients receiving implant treatment. 
Two hundred and ninety-one patients were divided into four groups: a no-periodontitis (np) 
group, a mild-periodontitis (mip) group, a moderate-periodontitis (mop) group, and a 
severe-periodontitis (sp) group. The levels of the following five periodontal pathogens in 
saliva were evaluated using real-time polymerase chain reaction: Porphyromonas 
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gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, Treponema 
denticola, and Prevotella intermedia. The levels of P. gingivalis and T. forsythia were 
significantly higher in mop group than in np group (p < 0.05). The levels of all periodontal 
pathogens tested except A. actinomycetemcomitans were significantly higher in sp group 
than in np group (p < 0.05). The detection levels of the periodontal pathogens targeted in 
saliva samples were correlated with the periodontal status.  
According to the information collected in the literature, peri-implant 
environment presents a complex microbiota that can be harbored by known 
periodontopathic bacteria. In this context patients with history of periodontal disease could 
present reservoirs of gram-negative bacteria that would colonize the peri-implant sulcus. 
So, history of periodontal disease should be evaluated cautiously and any type of 
periodontal disease has to be treated before dental implant insertion.  Also, the care with 
this kind of patient needs to continue after oral rehabilitation with implants to avoid or treat 
peri-implant diseases. 
 
Immunological aspects of implants  
Peri-implant diseases present inflammatory component and alterations in 
citokines levels occurred in the peri-implant tissues. The early detection of these alterations 
could help clinicians to avoid or to treat mucositis and peri-implantitis increasing the 
longevity of oral rehabilitation with dental implants. Therefore, the analysis of peri-implant 
crevicular fluid (PICF) would offer a non-invasive mean of studying the host response in 
peri-implant disease and might provide an early indication of patients at risk for active 
disease.   
Petkovic et al. (2010) examined the PICF levels of interleukin-1beta (IL-1b), 
tumour necrosis factor alpha (TNF-α), interleukin-8 (IL-8) and macrophage inflammatory 
protein-1alpha (MIP-1α) in patients with non-manifesting inflammation, early and late 
stages of mucositis. The authors evaluated 90 adult healthy volunteers with dental implants 
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inserted. Implant tissues were categorized clinically as healthy, early mucositis or advanced 
mucositis. Patients from the control group (healthy patients) had significantly lower 
concentrations of IL-1b, TNF- α, IL-8 and MIP-1 α in PICF compared with both groups 
with mucositis. Positive correlation was noticed in the control group between IL-1b and 
TNF- α and between MIP-1 α and IL-8 in the group with early mucositis. The results 
suggest that cytokines could be prognostic markers of implant failure. 
Rakic et al. (2012) investigated the levels of biomarkers associated with 
osteoclastogenesis in patients suffering peri-implantitis and compared them with levels in 
healthy peri-implant sites and severe chronic periodontitis. Peri-implant/gingival crevicular 
fluid samples and clinical parameters were collected from 70 patients (23 with peri-
implantitis, 25 with healthy peri-implant tissues and 22 with severe chronic periodontitis). 
The concentrations of sRANKL, RANK and OPG were evaluated using enzyme-linked 
immunosorbent assays. sRANKL (p = 0.01), RANK (p = 0.01) and OPG (p = 0.03) 
concentrations were significantly higher in peri-implantitis sites when compared to those in 
healthy implant sites, although differences in the sRANKL/OPG ratio were not statistically 
significant. In these sites all three markers were significantly correlated with the clinical 
parameters, with exception of OPG/plaque index correlation that remained insignificant (p 
= 0.121). When comparing peri-implantitis and periodontitis findings, RANK was 
significantly higher in peri-implantitis sites whereas, sRANKL (p = 0.03) and 
sRANKL/OPG ratio (p = 0.004) were significantly higher in periodontitis sites. Among 
periodontitis and healthy implant sites the same differences have been observed for both 
sRANKL (p = 0.000) and sRANKL/OPG ratio (p = 0.000), furthermore RANK was higher 
in periodontitis sites as well (p = 0.010). In conclusion, these results suggested that the 
PICF levels of biomarkers sRANKL, RANK, and OPG are associated with peri-implant 
tissue destruction and the pattern of these biomarkers differed when compared to 
periodontitis. 
Fonseca et al. (2012) aimed to measure the levels of GM-CSF, IL-1b, IL-2, IL-
4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IFN-c and TNF-α in peri-implant crevicular fluid 
(PICF) and saliva from patients with peri-implant disease. In PICF, the levels of IL-1b were 
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significantly higher in shallow peri-implantitis sites compared to mucositis (p = 0.03). In 
the saliva from parotid, IL-8 and IL-12 were significantly higher in patients with peri-
implantitis (p = 0.04). The authors concluded that elevated levels of IL-1b in PICF seem to 
be a characteristic trait of patients with peri-implantitis. 
Güncü et al. (2012) aimed to analyze PICF interleukin-1 beta (IL-1b), IL-10, 
osteoprotegerin (OPG), receptor activator of nuclear factor-kappa B ligand (RANKL) 
levels to determine whether the diagnostic value of PICF can be used to evaluate early 
changes around implants. A total of 47 dental implants either healthy/non-inflamed (n = 20) 
(Group I), or gingivitis/inflamed (n = 27) (Group II), were classified. Volume of PICF was 
statistically higher in Group II. IL-1b, IL-10 and OPG levels in PICF were significantly 
higher in Group II. RANKL levels did not differ between groups. These data suggest that a 
balance of inflammatory and osteoclastogenesis related molecules locally produced may 
play an important role in the development of inflammatory peri-implant lesions. 
Emecen-huja et al. (2013) evaluated peri-implant (PICF) and gingival 
crevicular fluids (GCF) at surgery and 12 weeks after implant insertion in 40 subjects. PICF 
volume decreased threefold by week 12 (p = 0.0003). IL-6, IL-8, MIP-1b and TIMP-1 
levels significantly increased at surgical sites at week one, significantly decreasing 
thereafter (p < 0.016). Peri-implant gingival healing, as determined by crevicular fluid 
molecular composition, differed from periodontal healing. The observed differences 
suggest that peri-implant tissues, compared to periodontal tissues, represent a higher pro-
inflammatory state. 
Yaghobee et al. (2013) investigated the relationship between the concentration 
of IL-1ᵦ in gingival crevicular fluid (GCF) and peri-implant crevicular fluid (PICF) and 
clinical parameters such as plaque index (PI), gingival index (GI), pocket depth (PD) and 
bone loss (BL). The authors evaluated 32 patients and found positive correlation between 
the level of IL-1ᵦ and PI, GI, PD and BL in implants and in teeth (p < 0.0001). In similar 
conditions, the level of IL-1ᵦ was greatly higher in PICF than GCF (75.26 pg/µl and 45.71 
pg/µl, respectively) (p = 0.001). So, the findings of the present study indicated that the level 
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of IL-1ᵦ may be an important supplement to clinical findings in measuring the health status 
of gingival or peri-implant tissues. 
There are few studies in the literature regarding peri-implant cytokines levels. 
So no consensus could be achieved and more studies should be developed to clarify this 
issue.  
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3 PROPOSITION/PROPOSIÇÃO 
  
The aim of this study was to evaluate clinical, microbiological, and 
immunological patterns of dental implants placed in healthy, partially edentulous, patients 
(HH), and those with a history of aggressive (HGAgP) or chronic periodontitis (HGCP), 
considering the null hypothesis that there are no differences between groups. 
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4 MATERIAL AND METHODS/MATERIAL E MÉTODOS 
 
Study Population and Design 
The study protocol and informed consent form were approved by the Ethics 
Committee of Piracicaba Dental School (number 017/2010).  
This prospective, parallel, controlled clinical trial was designed in accordance 
with the CONSORT Statement (Moher et al., 2010). The study began with 49 partially 
edentulous patients who had accepted a treatment plan for single-tooth implant-retained 
rehabilitation. The convenience sample was recruited from the Graduate Periodontology 
Clinic of Piracicaba Dental School – State University of Campinas, Piracicaba, Brazil. The 
selection occurred between March 2011 and October 2012. 
Inclusion criteria were: (1) patients aged ≥ 18 yrs; (2) single missing tooth with 
adjacent teeth present; (3) diagnosis of health or history of generalized chronic or 
generalized aggressive periodontitis (Armitage, 1999) previously treated with at least 1 year 
of supportive periodontal therapy (SPT) – patients of generalized chronic or aggressive 
periodontitis had to be treated by the own group and had to participate in SPT in the 
Periodontology Clinic of Piracicaba Dental School; and (4) signing of the informed 
consent. Exclusion criteria were: (1) the presence of systemic diseases that possibly affect 
the healing process, e.g., diabetes; (2) smoking habits; (3) no adherence to SPT; (4) 
antibiotic therapy within 6 months prior to implant placement; (5) women who were 
pregnant or lactating; (6) the absence of keratinized tissue at the implant site – it could be 
interfere in hygiene around implants; (7) the need for antibiotic prophylaxis or post-
operative antibiotic coverage; (8) the need for a simultaneous hard- or soft-tissue graft; (9) 
untreated periodontitis; and (10) inability or unwillingness to comply with study procedures 
and follow-up visits. Exit criteria were: (1) voluntary withdrawal; (2) non-compliance with 
study procedures or visits; (3) development of systemic or oral diseases requiring antibiotic 
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therapy; and (4) development of peri-implant infection/alteration requiring surgical 
intervention. 
All those enrolled in this study received explanations about the possibilities of 
oral rehabilitation and provided signed written informed consent prior to entering the study. 
The patients were divided into three groups according to their periodontal history, as 
follows: 
HGAgP group (14) – those who had a history of generalized aggressive periodontitis; 
HGCP group (20) – those who had a history of generalized chronic periodontitis; and 
HH group (15) – those who had no history of periodontitis and presented tooth loss due to 
caries, trauma or endodontic reasons.  
Before patients entered the study, molds were made, and casts were provided 
for diagnostic waxing of each clinical case. Tomographic examinations were analyzed, and 
a custom-made multifunctional acetate stent was manufactured for surgical guidance and 
clinical evaluations. Patients were examined monthly after implant surgery up to six 
months after implants were loaded. During these visits, supportive periodontal treatment 
was performed. According to the patient’s needs, oral hygiene instruction, supragingival 
calculus removal, prophylaxis with rubber cups, and subgingival debridement of pockets 
presenting PD ≥ 5 mm and BOP were performed.   
 
Calibration  
Three random patients presenting with GAgP were selected so that the 
examiner could perform the calibration. The designated examiner (HFV) measured relative 
clinical attachment level (rCAL) and probing depth (PD) of teeth in all three patients twice 
within 24 h, with an interval of ≥ 1 h between examinations. The intraclass correlation was 
calculated for each parameter, resulting in 90% reproducibility for relative CAL and 91% 
for PD. These patients did not enter the clinical trial. 
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Surgical Protocol 
Before surgery, each patient’s oral cavity was rinsed with 0.12% chlorhexidine 
for 1 min. Intraoral anti-inflammatory therapy consisting of 4 mg dexamethasone was 
provided 1 h before surgery. 
All implants included in this study were manufactured by Straumann (Institut 
Straumann AG, Basel, Switzerland). The implants were all of the tissue-level type 
(standard plus) with sandblasted acid-etched (SLA) surfaces. Screw-type dental implants 
were placed by the same operator (TTV, instructed by MZC). After local anesthesia (4% 
Articaine with epinephrine 1:100,000; DFL Indústria e Comércio S.A., Rio de Janeiro, RJ, 
Brazil), a midcrestal incision was made, and full-thickness buccal and palatal/lingual 
mucoperiosteal flaps were reflected. The implants were inserted according to a standard 
one-stage surgical protocol following the manufacturer´s recommendations and using the 
manufacturer-specified surgical burs. All implants were placed leaving 1.8 mm of polished 
collar in the supra-osseous condition (according to the manufacturer´s instructions).  
After implant placement, a manufacturer-provided healing abutment was 
inserted, and soft tissues were sutured with interrupted non-resorbable sutures. Patients 
were instructed to rinse the surgical site with 0.12% chlorhexidine twice a day for 7 days. 
Sutures were removed 7 days after surgery, and patients were instructed to resume their 
usual mechanical oral hygiene.   
 
Prosthetic Rehabilitation 
All clinical prosthetic procedures were performed by the same operator 
(MCCG, instructed by FHBA). The prosthetic procedures began 2 months after surgery. 
Metalloceramic screw-retained prostheses were manufactured by diagnostic waxing with 
Syn Octa components (Straumann). Implants were loaded with single crowns 3 months 
after surgery, and adjustments were made following the patients’ maximum habitual 
intercuspation.  
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Clinical Parameters 
Full-mouth clinical evaluations were obtained by means of a manual probe 
(PCPUNC 15
®
, HuFriedy, Chicago, IL, USA) before implant placement, at the day of 
prosthesis installation, and 1, 3, and 6 months after implant loading.  
The following clinical parameters were evaluated at implant and tooth sites: (1) 
the presence of plaque, according to Ainamo and Bay (1975); (2) bleeding on probing 
(BOP), according to Mühlemann and Son (1971); (3) probing depth (PD); (4) relative 
gingival margin position (rGMP), the distance from the gingival margin to the stent margin; 
and (5) relative clinical attachment level (rCAL), the distance from the bottom of the 
pocket to the stent margin. Relative CAL and rGMP were obtained by use of the 
measurement stent. 
At the time of implant placement, insertion torque (manual torquimeter; 
Straumann) and implant stability were obtained. Implant stability was also observed 
immediately before implant loading. Implant stability was measured via resonance 
frequency analysis (RFA) with the Osstell ISQ device (Osstell, Gothenburg, Sweden). A 
transducer (Smartpeg; Osstell) was manually screwed to the implant. The probe was held 
close to it in a mesio-distal direction during the evaluation. For improved precision and 
assessment of repeatability, two additional implant stability measurements were obtained. 
A single representative implant stability value was computed by the averaging of the three 
values.   
 
Radiographic Evaluation 
Radiographic stents were manufactured to standardize the x-ray incidence. The 
long-cone parallel technique was performed 7 days after implant surgery, at implant 
loading, and 6 months thereafter.  The periapical films were automatically processed 
(Gendex GXP Dental X-ray Processor; Gendex Dental Systems, Hatfield, PA, USA) and 
digitized by a scanner (HP model G4050; Hewlett-Packard Development Company, L.P. 
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Palo Alto, CA, USA). All radiographs were evaluated by the same calibrated operator 
(MAGP; intraclass correlation of 0.91) blinded for clinical conditions.  
Linear dimensions were calibrated to account for any distortion and 
magnification resulting from the imaging process. This was conducted by the use of a wire 
with known length associated with the radiographic stent. Measurements were recorded 
from the implant shoulder to the most coronal visible bone-to-implant contact on the mesial 
and distal sides of each implant, with UTHSCSA ImageTool software (Version 3.0). We 
computed a single representative bone-to-implant contact value by averaging both 
measurements. 
 
Microbiologic and Immunologic Parameters 
Peri-implant biofilm samples were collected from implant sites. Following 
supragingival biofilm removal and relative isolation with cotton rolls, four sterile 
paperpoints (#40) were inserted into the bottoms of the peri-implant sulci for 30 s (mesial, 
distal, lingual, and buccal). The paperpoints were placed in sterile tubes containing 300 μL 
of 0.5-mM Tris-EDTA and stored at -20
o
C until further processing. Biofilm samples were 
collected at implant loading, and 1, 3, and 6 months thereafter. 
Peri-implant crevicular fluid (PICF) was collected from mesial and distal sides 
of each implant after relative isolation and gentle drying. PICF was collected by the 
insertion of filter paper strips (Periopaper, Oraflow, Plainview, NY, USA) into the peri-
implant sulci until the examiner perceived a slight resistance. The strips were maintained in 
place for 15s. The fluid volume was measured with a calibrated electronic device (Periotron 
8000; Oraflow), and the strips were placed in sterile tubes containing 400 μL phosphate-
buffered saline (PBS) with 0.05% polysorbate 20 (Tween 20, Sigma-Aldrich, St. Louis, 
MO, USA). Both peri-implant biofilm and PICF samples were immediately stored at -20
o
C. 
Peri-implant crevicular fluid was collected 15 days after implant surgery, at implant 
loading, and 6 months thereafter.  
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Microbiologic Evaluation 
All microbiologic and immunologic parameters were evaluated by the same 
operator (TT) blinded for clinical conditions. The presence and concentration of 
Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf), and Aggregatibacter 
actinomycetemcomitans (Aa) were evaluated with specific primers reported in the literature 
(Del Peloso Ribeiro et al., 2008; Casarin et al., 2010) by a real-time polymerase chain-
reaction (PCR) technique. 
Initially, DNA was extracted from the peri-implant biofilm with a DNA 
extraction kit (QIAamp DNA Mini Kit; Qiagen Inc., Valencia, CA, USA). Real-time PCR 
was performed with the hot-start reaction mix for PCR (FastStart DNA Master SYBR 
Green I; Roche Diagnostics, Mannheim, Germany). The concentration of DNA used in 
each run was 10 mg/mL. The amplification profiles were as follows: 95/10, 55/5, 72/4 
[temperature (1°C)/time (s)], and 40 cycles for Pg; 95/10, 46/5, 72/5, and 45 cycles for Tf; 
and 95/10, 55/5, 72/3, and 40 cycles for Aa. Melting peaks were used to determine the 
specificity of the PCR. 
Absolute quantification of target bacteria in clinical samples was performed 
with Pg (ATCC 33277), Tf (ATCC 43037), and Aa (JP2) as controls. Standard curves were 
made with these controls and used to convert cycle threshold scores into the number of 
bacterial cells, using controls with known amounts of bacterial-specific DNA. The level of 
detection was set at 10
3
 bacteria/plaque sample for all target bacteria. The determination of 
DNA content in controls was based on the genome size of each bacteria and the mean 
weight of one nucleotide pair.  
 
GCF Cytokine Levels and Bone Markers 
Cytokine levels [granulocyte macrophage colony-stimulating factor (GM-CSF), 
interferon (IFN)-γ, interleukin (IL)-1β, IL-4, IL-6, IL-8, IL-10, and tumor necrosis factor 
(TNF-α)] in GCF were determined with the high-sensitivity human cytokine 10-plex 
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(Millipore Corporation, Billerica, MA, USA). Assays were carried out according to the 
manufacturer’s recommendations with the MAGPIX® instrument (MiraiBio, Alameda, CA, 
USA). The samples were individually analyzed (each pocket separately), and 
concentrations were estimated from the standard curve according to a five-parameter 
polynomial equation with Xponent software (Millipore Corporation). The mean 
concentration of each marker was calculated based on the individual as a statistical unit and 
expressed as pg/mL. 
The levels of the bone markers (OPG and RANKL) were determined with the 
LUMINEX/MAGPIX
®
 system (HBN1A-51K and HCCBP1MAG-58K; Millipore 
Corporation). The samples were analyzed individually, and the levels were estimated based 
on a 5-parameter polynomial curve (Xponent software, Millipore Corporation). All results 
were adjusted for peri-implant crevicular fluid volume collected in each implant, and values 
were expressed in pg/mL. 
  
Statistical Analysis  
The analyses were performed by a blinded examiner (RCVC) who did not 
know the patients’ status before the results. Only data from patients complying with all the 
evaluations were used in the statistical analysis. The analyses were performed with SAS 9.1 
(SAS Software; SAS Institute, Cary, NC, USA) and Bioestat 5.0 (Instituto Mamirauá, 
Belém, PA, Brazil) with a significance level of 0.05. 
Numeric variables such as patient age, implant stability, PD, rCAL, rGMP, 
plaque index (PI), BOP, radiographic bone loss, and microbiological and immunological 
variables were initially evaluated by the Shapiro-Wilk test (for normality). Those 
presenting a Shapiro-Wilk p-value > 0.05 were analyzed by ANOVA followed by Tukey’s 
HSD test. Those presenting a Shapiro-Wilk p-value ≤ 0.05 were analyzed by the Friedman 
test (intragroup comparisons) and Kruskal-Wallis/Dunn tests (intergroup comparisons).       
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Comparisons among groups in terms of gender, frequency of implant length, 
implant diameter, torque insertion, presence of implant plaque, and implant BOP were 
performed by Fisher’s Exact test. 
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5 RESULTS/RESULTADOS 
 
Clinical Results 
The patients’ follow-up period is shown in Fig. 1. Four patients were excluded 
from the study during the 3-month interval between implant placement and prosthesis 
installation. One patient withdrew from the study, and three patients used systemic 
antibiotics because of health problems. Thus, 45 patients completed the six-month follow-
up period, 13 of those presenting a history of generalized aggressive periodontitis, 18 
presenting generalized chronic periodontitis, and 14 presenting no history of periodontitis. 
 
 
Figure 1 – Flow chart of the study. HGAgP = history of generalized aggressive 
periodontitis. HGCP = history of generalized chronic periodontitis. HH = no 
history of periodontitis. 
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In analyses of the demographics and clinical parameters (Table 1), no 
differences among groups were found in terms of gender, initial full-mouth PI, and BOP (p 
> 0.05). Patients’ ages differed among groups, so those in the HGAgP group presented as 
33.31 ± 3.82 yrs old at baseline, which was lower than the age presented by those in the 
HGCP and HH groups (49.89 ± 6.84 and  45.36 ± 11.70 yrs old, respectively) (p < 0.05). 
Those in the HH group presented lower values (p < 0.05) of clinical parameters such as 
full-mouth PD, rCAL, and rGMP compared with those in the HGAgP and HGCP groups. 
 
Table 1 – Study population demographic and clinical parameters evaluated before dental implant insertion 
Parameter HGAgP Group HGCP Group HH Group 
Age (yrs – mean ± SD) 33.31 ± 3.82 b 49.89 ± 6.84 a 45.36 ± 11.70 a 
Gender - Woman – n (%) 11 (84.62%) 13 (72.22%) 8 (57.14 %) 
p-value 0.2988   
    
Full-mouth PD (mm - mean ± SD) 2.42 ± 0.29 a 2.32 ± 0.30 a 2.06 ± 0.29 b 
Full-mouth rCAL (mm - mean ± SD) 5.54 ± 0.99 a 5.48 ± 0.81 a 4.57 ± 0.69 b 
Full-mouth rGMP (mm - mean ± SD) 3.12 ± 0.82 ab 3.17 ± 0.65 a 2.51 ± 0.64 b 
Full-mouth PI (mm - mean ± SD) 18.86 ± 14.76 a 20.18 ± 13.67 a 26.07 ± 12.66 a 
Full-mouth BOP (mm - mean ± SD) 17.15 ± 7.76 a 17.29 ± 7.41 a 17.68 ± 7.00 a 
Distinct lowercase letters in a row indicate statistically significant difference by one-way ANOVA/Tukey’s 
HSD test (p < 0.05).Gender parameter frequencies were analyzed by Fisher’s Exact test. 
Probing depth (PD), relative clinical attachment level (rCAL), relative gingival margin position (rGMP), 
plaque index (PI), and bleeding on probing (BOP). 
  
According to the characteristics of the implants used during the study, all 
groups received implants 8, 10, and 12 mm long. In all groups, the 12-mm-long implant 
presented low frequency of use (23.08% HGAgP, 16.67% HGCP, and 13.33% HH). 
Implant lengths of 8 mm and 10 mm were the most common in this study, regardless of the 
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patient’s periodontal history. No differences among groups were observed for frequency of 
implant length (Table 2). 
Table 2 presents a comparison among groups for the frequencies of indication 
of each implant diameter. There was no difference among groups for the frequencies of 3.3-
, 4.1-, and 4.8-mm-diameter implants used in each group (p > 0.05).  
The insertion torque was divided into 3 classes: less than or equal to 15N, 
between 15N and 35N, and more than or equal to 35N. When frequencies of torque found 
in each group were considered, no differences were obtained among the groups (Table 2). 
 
Table 2 – Comparison among groups in terms of the frequencies of implant length (mm), implant 
diameter (mm), and torque obtained at the time of implant placement (N) 
Parameter 
HGAgP Group 
n=13 
HGCP 
Group n=18 
HH Group 
n=14 
p-value 
Implant 
length 
8 mm – n (%) 4 (30.77%) 8 (44.44%) 7 (46.67%) 
0.9190 10 mm – n (%) 6 (46.15%) 7 (38.89%) 6 (40.00%) 
12 mm – n (%) 3 (23.08%) 3 (16.67%) 2 (13.33%) 
      
Implant 
diameter 
3.3 mm – n (%) 3 (23.08%) 5 (27.78%) 1 (6.67%) 
0.3455 4.1 mm – n (%) 9 (69.23%) 9 (50.00%) 9 (60.00%) 
4.8 mm – n (%) 1 (7.69%) 4 (22.22%) 5 (33.33%) 
      
Insertion 
torque 
≥ 35 N 7 (53.85%) 9 (50.00%) 4 (26.67%) 
0.5337 15 < torque <35 4 (30.77%) 4 (22.22%) 6 (40.00%) 
≤ 15N 2 (15.38%) 5 (27.78%) 5 (33.33%) 
Frequencies were compared by Fisher’s Exact test.  
  
Comparisons of initial implant stability measured by the Osstell ISQ device are 
shown in Table 3. The intergroup comparisons at the implant insertion and at the prosthesis 
installation did not show differences among the patient groups (p > 0.05). Nonetheless, the 
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intragroup analyses showed higher values of implant stability at the loading time than at 
surgery, in all groups (p < 0.05).  
 
Table 3 – Comparisons among groups in terms of implant stability (ISQ), measured by the Osstell ISQ 
device, obtained at implant insertion and at implant loading. 
Time HGAgP Group HGCP Group HH Group 
Implant insertion 72.70 (± 4.23) Ba 71.96 (± 10.93) Ba 74.59 (± 6.20) Ba 
Implant loading 78.92 (± 4.82) Aa 79.30 (± 3.67) Aa 82.23 (± 5.87) Aa 
Distinct uppercase letters in a column and distinct lowercase letters in a row indicate statistically 
significant differences by ANOVA/Tukey’s HSD test (p ≤ 0.05). 
 
During the study period, those in the HH group presented PD and rCAL values 
lower than those in the HGAgP and HGCP groups (Table 4, Figure 2). No intragroup 
differences (p > 0.05) were seen during the follow-up period. Thus, stable periodontal 
conditions were maintained in all groups from the time of dental implant surgery until the 
6
th
 month after loading.  
In terms of the implant sites, no difference among the HGAgP, HGCP, and HH 
groups was observed during the study period (Table 5). Probing-depth intragroup 
differences (p < 0.05) were seen in the HGCP and HH groups when baseline levels were 
compared with those at 6 months after loading. When the gain or loss of PD during the 
study period was compared, no difference was observed among the groups (p > 0.05). 
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Table 4 – Inter- and intragroup comparisons in terms of averages (± SD) of full-mouth probing depth (PD), 
full-mouth relative clinical attachment level (rCAL), and relative gingival margin position (rGMP) obtained 
during the study.  
Parameters Baseline 
Prosthesis 
Installation 
1 Month of 
Loading 
3 Months of 
Loading 
6 Months of 
Loading 
Full-mouth PD 
(mm)      
HGAgP 2.42 ± 0.29 Aa 2.36 ± 0.23 Aa 2.33 ± 0.28 Aa 2.38 ± 0.35 Aa 2.28 ± 0.31 Aa 
HGCP 2.32 ± 0.30 Aa 2.23 ± 0.28 ABa 2.18 ± 0.27 Ba 2.22 ± 0.31 Ba 2.24 ± 0.33 ABa 
HH 2.06 ± 0.29 Ba 2.11 ± 0.22 Ba 2.09 ± 0.19 Ba 2.10 ± 0.20 Ba 2.17 ± 0.20 Ba 
      
Full-mouth 
rCAL (mm) 
     
HGAgP 5.54 ± 0.99 Aa 5.78 ± 1.11 Aa 5.85 ± 1.18 Aa 6.06 ± 1.58 Aa 5.73 ± 1.10 Aa 
HGCP 5.48 ± 0.81 Aa 5.62 ± 0.78 ABa 5.57 ± 0.84 ABa 5.60 ± 0.91 ABa 5.63 ± 0.84 Aa 
HH 4.57 ± 0.69 Ba 4.89 ± 0.70 Ba 4.80 ± 0.71 Ba 4.85 ± 0.72 Ba 4.94 ± 0.73 Aa 
      
Full-mouth 
rGMP (mm)      
HGAgP 3.12 ± 0.82 ABa 3.42 ± 1.03 Aa 3.53 ± 1.11 Aa 3.68 ± 1.34 Aa 3.45 ± 0.96 Aa 
HGCP 3.17 ± 0.65 Aa 3.46 ± 0.76 Aa 3.38 ± 0.75 Aa 3.37 ± 0.77 Aa 3.40 ± 0.74 Aa 
HH 2.51 ± 0.64 Ba 2.78 ± 0.69 Aa 2.71 ± 0.68 Aa 2.75 ± 0.71 Aa 2.76 ± 0.73 Aa 
In PD, distinct uppercase letters in a column and distinct lowercase letters in a row indicate statistically 
significant differences by ANOVA/Tukey’s HSD test (p ≤ 0.05). In rCAL and rGMP, distinct uppercase letters 
in a column indicate statistically significant differences by the Kruskal Wallis/Dunn tests (p < 0.05), and 
distinct lowercase letters in a row indicate statistically significant differences by the Friedman test (p ≤ 0.05). 
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Figure 2 – Frequency (%) of full-mouth plaque index (PI) and bleeding on probing (BOP) during follow-up 
period. Both PI and BOP showed no differences in intra- or intergroup comparisons by ANOVA/ Tukey’s 
HSD test (p > 0.05). 
 
For rCAL at implant sites, only the HGAgP group showed differences among 
the evaluations (Table 5). In this group, the values obtained at the 3
rd
 and 6
th
 months of 
evaluation (7.97 ± 2.07 and 7.89 ± 2.26 mm, respectively) were higher than those obtained 
at the 1
st
 month of loading (7.46 ± 2.00 mm) (p < 0.05). This difference was also found 
when gain or loss in the rCAL parameter (Table 5) was compared in the HGAgP group. In 
the first month, there was a gain of 0.24 ± 0.58 mm compared with baseline, and losses of 
0.26 ± 0.71 and 0.24 ± 0.58 mm were seen at the 3rd and 6th months. The HGCP and HH 
groups did not show intragroup differences (p > 0.05). 
rGMP analyses showed no difference among groups in the averages obtained 
after implant loading. However, the analysis of gain/loss of rGMP presented intra- and 
intergroup differences. Only the HGAgP group presented intragroup differences between 
gain at the 1
st
 month (0.15 ± 0.50 mm) and loss at the 3
rd
 month after loading (0.19 ± 0.55 
mm) (p < 0.05). Inter-group comparisons showed differences among all groups at the 3- 
and 6- month evaluations. At the 3
rd
 month after loading, the HGAgP group presented loss 
of 0.19 ± 0.55 mm, and the HGCP and HH groups presented gains of 0.25 ± 0.41 and 0.18  
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Table 5 – Intra- and intergroup comparisons of average (± SD) of clinical parameters [probing depth (PD), 
relative clinical attachment level (rCAL), and relative gingival margin position (rGMP)] obtained at implant 
sites and the clinical gain/loss in each parameter during the study. 
Parameter 
Time ∆ 1st – 
Prosthesis 
Inst. 
∆ 3rd – 
Prosthesis 
Inst. 
∆ 6th – 
Prosthesis 
Inst. 
Prosthesis 
Installation 
1st month  3rd month 6th month 
Implant PD 
(mm) 
        
   
HGAgP 
2.59 ± 0.47 
Aa 
2.51 ± 0.44 
Aa 
2.64 ± 0.50 
Aa 
2.65 ± 0.43 
Aa 
-0.08 ± 0.36 
Aa 
0.04 ± 0.46 
Aa 
0.05 ± 0.46 
Aa 
HGCP 
2.51 ± 0.43 
Ab 
2.61 ± 0.41 
Aab 
2.69 ± 0.47 
Aab 
2.83 ± 0.41 
Aa 
0.10 ± 0.44 
Aa 
0.18 ± 0.39 
Aa 
0.32 ± 0.49 
Aa 
HH 
2.85 ± 0.59 
Ab 
3.04 ± 0.56 
Aab 
3.13 ± 0.58 
Aab 
3.27 ± 0.75 
Aa 
0.23 ± 0.45  
Aa 
0.31 ± 0.43 
Aa 
0.47 ± 0.52 
Aa 
        
Implant 
rCAL (mm)            
HGAgP 
7.71 ± 2.00 
Aab 
7.46 ± 2.00 
Ab 
7.97 ± 2.07 
Aa 
7.89 ± 2.26 
Aa 
-0.24 ± 0.58  
Ab 
0.26 ± 0.71 
Aa 
0.24 ± 0.58 
Aa 
HGCP 
7.05 ± 1.61 
Aa 
7.08 ± 1.53 
Aa 
6.91 ± 1.70 
Aa 
7.17 ± 1.60 
Aa 
0.02 ± 0.59  
Aa 
-0.07 ± 0.54 
Aa 
0.11 ± 0.53 
Aa 
HH 
6.26 ± 2.59 
Aa 
6.29 ± 2.45 
Aa 
6.24 ± 2.34 
Aa 
6.46 ± 2.40 
Aa 
0.13 ± 0.65  
Aa 
0.08 ± 0.76 
Aa 
0.32 ± 0.81 
Aa 
        
Implant 
rGMP            
HGAgP 
5.03 ± 1.79 
Aa 
4.87 ± 1.73 
Aa 
5.21 ± 1.68 
Aa 
5.08 ± 1.86 
Aa 
-0.15 ± 0.50  
Ab 
0.19 ± 0.55 
Aa 
0.12 ± 0.56 
Aab 
HGCP 
4.54 ± 1.31 
Aa 
4.46 ± 1.44 
Aa 
4.22 ± 1.46 
Aa 
4.34 ± 1.57 
Aa 
-0.08 ± 0.37  
Aa 
-0.25 ± 0.41 
Ba 
-0.21 ± 0.47 
Ba 
HH 
3.56 ± 1.98 
Aa 
3.42 ± 1.89 
Aa 
3.30 ± 1.83 
Aa 
3.37 ± 1.89 
Aa 
-0.06 ± 0.50  
Aa 
-0.18 ± 0.64 
Ba 
-0.11 ± 0.61 
ABa 
In comparisons of clinical implant parameters and clinical gain/loss, distinct uppercase letters in a column 
and distinct lowercase letters in a row indicate statistically significant differences by ANOVA/Tukey HSD 
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tests (p ≤ 0.05). In the clinical gain/loss table, negative values indicate gains in clinical parameters, and 
positive values indicate loss in clinical parameters. 
 
± 0.64 mm, respectively (p < 0.05). At the 6-month evaluation, HGAgP presented a loss of 
0.12 ± 0.56 mm, and HGCP presented a gain of 0.21 ± 0.47 mm (p < 0.05). 
The frequencies of the numbers of implants presenting visible plaque during the 
evaluations are shown in Fig. 3. The intergroup comparisons of these frequencies, 
performed at each time period, showed no statistically significant differences (p > 0.05). 
The frequencies of implants presenting at least one site with BOP are also shown in Fig. 3. 
These frequencies were high in all evaluations, and no statistically significant differences 
were seen in intra- or intergroup comparisons (p > 0.05).  
 
 
Figure 3 – Illustration of frequency of implants presenting visible plaque during the evaluations and 
frequency of implants presenting at least 1 site with bleeding on probing (BOP). No differences between the 
frequencies presented by each group were observed by Fisher´s Exact test (p>0.05). 
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Radiographic Results 
The results of radiographic analysis showed no differences among groups (p > 
0.05), but in all groups, intragroup comparisons already presented statistically significantly 
higher distances (p < 0.05) from platform to bone contact at the time of implant loading (p 
< 0.05). The quantity of bone resorption did not differ among groups at the time of implant 
loading or at the 6-month post-loading evaluation. Only the HH group presented higher 
values of resorption at the 6-month evaluation (1.14 ± 1.11 mm) compared with that at the 
time of implant loading (0.84 ± 0.91 mm).    
 
Table 6 – Comparison of the radiographic distances (mm) measured from the implant platform and the first 
implant-bone contact and the gain/loss bone comparisons at 3 distinct time-points of the study. 
Group 
Time ∆ Implant 
Loading – 
Implant 
Insertion 
∆ 6-month Loading – 
Implant Insertion 
Implant 
Insertion 
Implant 
Loading  
6 Months after 
Loading 
HGAgP 1.15 ± 1.03 Ab 1.70 ± 1.16 Aa 1.91 ± 1.20 Aa 0.54 ± 0.88 Aa 0.77 ± 1.32 Aa 
HGCP 1.61 ± 1.11 Ab 2.27 ± 1.00 Aa 2.37 ± 0.98 Aa 0.67 ± 0.97 Aa 0.80 ± 0.94 Aa 
HH 1.28 ± 0.74 Ab 2.12 ± 0.48 Aa 2.43 ± 0.67 Aa 0.84 ± 0.91 Ab 1.14 ± 1.11 Aa 
In reference to distance, distinct uppercase letters in a column indicate statistically significant differences by 
Kruskal-Wallis/Dunn tests (p < 0.05), and distinct lowercase letters in a row indicate statistically significant 
differences by Friedman´s test (p ≤ 0.05). In reference to resorption analysis, distinct uppercase letters in a 
column indicate statistically significant differences by Kruskal-Wallis/Dunn tests (p < 0.05), and distinct 
lowercase letters in a row indicate statistically significant differences by Wilcoxon´s test (p < 0.05). 
 
Immunologic Results 
The evaluation of inflammatory markers showed no differences among groups 
for all variables (Table 7) except for IL-4, which, at 6 months after loading, presented lower 
levels in those in the HGAgP and HGCP groups compared with those in the HH group. 
Only those in the HGAgP group presented differences in IL-6 levels during the study. For 
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this group, at the time of implant loading, the IL-6 level was higher (p < 0.05) than at 15 
days after surgery and 6 months after implant loading.   
 
Table 7 – Intra- and intergroup comparisons of immunological variables: GM-CSF, IFNγ, IL-10, IL-
1β, IL-8, IL-6, TNFα, and IL-4. 
Inflammatory 
Markers 
Time 
15 Days after 
Surgery 
Loading  
6 Months after 
Loading 
GM-CSF 
(pg/mL) 
   
HGAgP 0.10 ± 0.15 Aa 0.27 ± 0.32 Aa 0.14 ± 0.12 Aa 
HGCP 0.12 ± 0.21 Aa 0.17 ± 0.17 Aa 0.20 ± 0.23 Aa 
HH 0.00 ± 0.00 Aa 0.00 ± 0.00 Aa 0.00 ± 0.00 Aa 
    
IFNγ (pg/mL)    
HGAgP 0.46 ± 0.86 Aa 0.99 ± 1.83 Aa 0.09 ± 0.16 Aa 
HGCP 0.55 ± 1.00 Aa 1.04 ± 1.71 Aa 0.70 ± 1.29 Aa 
HH 0.71 ± 1.47 Aa 0.52 ± 0.69 Aa  0.94 ± 1.82 Aa 
    
IL-10 (pg/mL)    
HGAgP 2.08 ± 1.22 Aa 3.31 ± 2.62 Aa 1.54 ± 1.69 Aa 
HGCP 2.09 ± 2.48 Aa 3.83 ± 3.85 Aa 3.19 ± 3.37 Aa 
HH 0.97 ± 1.84 Aa 2.06 ± 3.21 Aa 1.22 ± 1.90 Aa 
      
IL-1β (pg/mL)    
HGAgP 4.01 ± 4.71 Aa 2.84 ± 3.85 Aa 0.99 ± 1.38 Aa 
HGCP 2.28 ± 3.05 Aa 2.54 ± 4.20 Aa 2.39 ± 3.34 Aa 
HH 0.78 ± 0.96 Aa 1.01 ± 1.91 Aa 3.32 ± 4.02 Aa 
For each immunological variable, distinct uppercase letters in a column indicate statistically 
significant differences by Kruskal Wallis/Dunn tests (p < 0.05), and distinct lowercase letters in a row 
indicate  statistically significant difference by Friedman´s test (p ≤ 0.05). 
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Cont. table 7 – Intra- and intergroup comparisons of immunological variables: GM-CSF, IFNγ, IL-10, 
IL-1β, IL-8, IL-6, TNFα, and IL-4. 
Inflammatory 
Markers 
Time 
15 Days after 
Surgery 
Loading  
6 Months after 
Loading 
IL-8 (pg/mL)    
HGAgP 185.13 ± 123.18 Aa 181.68 ± 160.17 Aa 110.76 ± 100.03 Aa 
HGCP 180.87 ± 219.28 Aa 262.01 ± 266.13 Aa 179.45 ± 243.83 Aa 
HH 114.20 ± 159.08 Aa 125.17 ± 157.94 Aa 59.73 ± 94.38 Aa 
    
IL-6 (pg/mL)    
HGAgP 0.32 ± 0.26 Ab 1.51 ± 3.75 Aa 0.40 ± 0.44 Ab 
HGCP 0.95 ± 1.17 Aa 0.40 ± 1.01 Aa 0.70 ± 1.46 Aa 
HH 0.28 ± 0.39 Aa 0.23 ± 0.35 Aa 0.21 ± 0.55 Aa 
    
TNFα (pg/mL)    
HGAgP 0.08 ± 0.16 Ab 0.05 ± 0.11 Ab 0.40 ± 0.70 Aa 
HGCP 0.04 ± 0.07 Ab 0.13 ± 0.31 Ab 1.10 ± 1.77 Aa 
HH 0.03 ± 0.05 Ab 0.11 ± 0.28 Ab 1.00 ± 1.51 Aa 
    
IL-4 (pg/mL)    
HGAgP 0.66 ± 0.45 Aa 0.89 ± 0.98 Aa 0.16 ± 0.25 Ba 
HGCP 1.73 ± 2.26 Aa 0.90 ± 1.10 Aa 0.48 ± 1.12 Ba 
HH 1.27 ± 1.91 Aa 1.26 ± 1.97 Aa 3.05 ± 5.07 Aa 
For each immunological variable, distinct uppercase letters in a column indicate statistically 
significant differences by Kruskal Wallis/Dunn tests (p < 0.05), and distinct lowercase letters in a row 
indicate  statistically significant difference by Friedman´s test (p ≤ 0.05). 
 
TNFα had similar responses in all groups (Table 7). The TNFα intragroup 
comparisons showed higher values (p < 0.05) at 6 months after implant loading, while 
lower values were seen at 15 days after surgery and at the time of implant loading. 
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The analyses of osteogenic markers such as OPG and RANKL presented 
differences among groups only at the time of implant loading in OPG levels. In this case, 
those in the HH group showed OPG levels higher (p < 0.05) than those in the HGAgP and 
HGCP groups. At the other measurement times, no intergroup differences were seen (p > 
0.05). 
Intragroup comparisons showed differences in the HGAgP group for the 
RANKL marker. The RANKL level at the time of loading was higher than that at 6 months 
after loading (Table 8). In terms of OPG levels, only those in the HH group presented lower 
levels (p < 0.05) at 15 days after surgery than at the time of implant loading and 6 months 
after loading.  
Table 8 – Intra- and intergroup comparisons of osteogenic markers: OPG and RANKL. 
Osteogenic 
Markers 
Time 
15 Days after 
Surgery 
Loading  
6 Months after 
Loading 
OPG (pg/mL)    
HGAgP 8.6 ± 7.4 Aa 19.7 ± 8.9 Ba 22.2 ± 23.9 Aa 
HGCP 3.9 ± 2.9 Aa 20.1 ± 10.8 Ba 12.8 ± 14.8 Aa 
HH 5.0 ± 0.8 Ab 40.5 ± 10.0 Aa 42.2 ± 19.9 Aa 
    
RANKL 
(pg/mL)    
HGAgP 7.4 ± 5.2 Aab 16.3 ± 7.9 Aa 6.1 ± 7.2 Ab 
HGCP 8.7 ± 10.1 Aa 13.5 ± 16.1 Aa 2.7 ± 3.2 Aa 
HH 2.2 ± 0.5 Aa 3.2 ± 1.8 Aa 3.1 ± 3.1 Aa 
For each osteogenic variable, distinct uppercase letters in a column indicate statistically 
significant differences by Kruskal Wallis/Dunn tests (p < 0.05), and distinct lowercase letters in a 
row indicate statistically significant difference by Friedman´s test  (p < 0.05). 
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Microbiologic Results 
 
Table 9 –Amounts of A. actinomycetemcomitans, P. gingivalis, and T. forsythia in peri-implant 
subgingival biofilm in patients either healthy or presenting a history of generalized aggressive 
periodontitis or generalized chronic periodontitis at the time of loading  and after 1, 3, and 6 months 
of loading. 
Bacteria 
Time 
Implant Loading 1st Month 3rd Month 6th Month 
Aa     
HGAgP 2.67 ± 3.01 Aa 2.71 ± 2.67 Aa 1.84 ± 2.52 Aa 2.32 ± 2.21 Aa 
HGCP 1.62 ± 1.42 Aa 0.40 ± 0.69 Ba 0.40 ± 0.70 Aa 1.13 ± 1.11 Aa 
HH 1.32 ± 1.87 Aa 0.32 ± 0.87 Ba 1.32 ± 1.87 Aa 1.33 ± 1.88 Aa 
     
Pg     
HGAgP 1.22 ± 2.02 Ab 
2.14 ± 1.93 
Aab 
3.19 ± 2.45 
Aab 
3.66 ± 2.50 Aa 
HGCP 0.84 ± 1.30 Ab 3.25 ± 2.20 Aa 3.31 ± 1.72 Aa 3.41 ± 1.86 Aa 
HH 1.33 ± 1.88 Aa 1.10 ± 1.56 Aa 2.21 ± 1.00 Aa 0.89 ± 0.78 Ba 
     
Tf     
HGAgP 3.70 ± 2.90 Ab 
4.64 ± 2.73 
Aab 
5.94 ± 0.87 Aa 3.49 ± 3.26 Ab 
HGCP 2.77 ± 1.75 Aa 4.05 ± 3.18 Aa 4.79 ± 2.42 Aa 5.00 ± 2.54 Aa 
HH 3.23 ± 2.04 Aa 4.84 ± 1.20 Aa 2.77 ± 3.91 Aa 3.57 ± 1.82 Aa 
Distinct uppercase letters in a column indicate statistically significant difference by Kruskal 
Wallis/Dunn tests (p < 0.05), and distinct lowercase letters in a row indicate statistically significant 
difference by Friedman´s test (p < 0.05). 
 
The microbiological evaluations for Aa, Pg, and Tf revealed differences among 
groups for Aa levels at the 1st month after implant loading (Table 9). At this time, those in 
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the HGAgP group showed Aa concentrations (2.71 ± 2.67) higher (p < 0.05) than those in 
the HGCP and HH groups. The Pg analyses showed differences among groups only at 6 
months after implant loading, while those in the HGAgP and HGCP groups presented 
higher levels of Pg than those in the HH group (Table 9). No differences among groups 
were seen for Tf levels (p > 0.05). 
Intragroup comparisons showed no differences among time evaluations for Aa. 
For Pg levels, those in the HGCP and HGAgP groups presented lower concentrations at 
implant loading (p < 0.05) and higher concentrations at 6 months after loading. In Tf 
analyses, only those in the HGAgP group showed differences among the evaluations, when 
the levels were higher at 3 months after loading and lower at implant loading and 6 months 
after loading.   
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6 DISCUSSION/DISCUSSÃO 
 
Healthy individuals and those with aggressive and chronic periodontitis have 
shown different clinical and radiographic outcomes after dental implant therapy, and long-
term evaluations have shown increased bone resorption, more risk for the development of 
mucositis and peri-implantitis, and lower survival and success rates for patients presenting 
a history of aggressive periodontitis (Al-Zahrani, 2008; Kim & Sung, 2012). Since this 
could be related to microbiologic and immunologic parameters, the present prospective, 
parallel, controlled clinical trial investigated the clinical, microbiological, and 
immunological parameters of dental implant rehabilitation in healthy partially edentulous 
patients and in those with a history of generalized aggressive and generalized chronic 
periodontitis.  
Initially, the patients were divided into three groups according to their history 
of previous periodontal disease. Age differences were observed among groups, but the ages 
of those with aggressive (33.31 ± 3.82 yrs old) and chronic (49.89 ± 6.84 yrs old) 
periodontitis were in agreement with classification system for periodontal diseases and 
conditions (Armitage, 1999).  
Clinical parameters showed lower values for full-mouth PD, rCAL, and rGMP 
in the HH group compared with those in the HGAgP and HGCP groups throughout the 
study. These differences were expected, since those in the HGAgP and HGCP groups had 
previously experienced tissue losses due to generalized periodontitis. In spite of these 
differences among groups, all patients were enrolled in supportive periodontal treatment 
which could be confirmed by full-mouth parameters of health during the study and the 
stability of full-mouth periodontal conditions maintained in each group. 
An expected difference among groups would be in implant length, diameter, 
and torque insertion. Periodontal diseases can promote severe attachment loss and bone 
resorption, reducing the quantity of bone available for implant insertion. The literature, 
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however, shows that periodontitis is not the only cause of tooth loss. Montandon et al. 
(2012)
 
reported caries and periodontitis as statistically significant reasons for tooth loss 
compared with factors such as endodontic problems, eruption problems, prosthetics, 
trauma, orthodontics, and occlusal problems. In periodontally healthy patients, the time of 
tooth loss could influence vertical and horizontal alveolar ridge resorption (Tan et al., 2012) 
and could explain why, in the present study, no among-group differences were observed 
relative to the implants used. The same 8-, 10-, and 12-mm implant lengths and the same 
3.3-, 4.1-, and 4.8-mm implant diameters were used in each group. Also, the same 
frequencies of torque insertion measurements were observed.      
Another characteristic evaluated was resonance frequency analysis (RFA), and 
among-group comparisons were made. This study showed, at implant insertion, close 
values of RFA among groups, without statistically significant differences. The absence of 
differences among groups observed at implant loading reinforced the contention that, at 
implant placement and at implant loading, periodontally healthy patients and those with 
aggressive and chronic periodontitis share the same RFA.  Studies have shown increased 
RFA readings after implant healing (Al-Juboori et al., 2013; Shokri et al., 2013), probably 
due to osseointegration. In agreement with this, in this study, RFA values increased from 
72.70, 71.96, and 74.59 ISQ units (HGAgP, HGCP, and HH groups, respectively) at 
implant insertion to 78.92, 79.30, and 82.23 ISQ units (HGAgP, HGCP, and HH groups, 
respectively) at implant loading.    
Although several previous studies have described a higher incidence of peri-
implantitis and lower success rates in patients treated for periodontitis (Safii et al., 2010; 
Donos, 2012; Marrone et al., 2013), this study did not show additional deterioration around 
implants in the periodontitis groups. In terms of clinical parameters obtained at implant 
sites, no differences among groups were found. The parameters rCAL and rGMP did not 
show different values in inter- and intragroup comparisons.  
During the 6 months after implant loading, the values of probing depth 
increased only around implants placed in the HGCP and HH groups, but at this time PD 
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values (HGAgP, 2.65 ± 0.43 mm; HGCP, 2.83 ± 0.41 mm; HH, 3.27 ± 0.75 mm) were 
similar to those reported by Cortelli et al. (2013) (3.02 ± 1.07 mm for healthy and 3.42 ± 
1.18 mm for mucositis implant sites), by Dierens et al. (2013) (3.8 ± 1.4 mm after 16 to 22 
years of function), and by Yaghobee et al. (2013) (3.31 ± 1.01 mm). It is probable that the 
PD values increased due to the higher frequency of BOP found during the follow-up period.  
In this study, in spite of monthly supportive periodontal treatment, all groups 
presented at least a 60% frequency of implant bleeding, and this constant inflammation 
could influence the probing depth during evaluations. Other studies also reported higher 
frequencies of implants presenting at least one site with BOP (DeAngelo et al., 2007; 
Lachmann et al., 2012). 
In spite of high implant BOP frequencies, little bone resorption around implants 
was observed up to 6 months after loading.  Among the many hypotheses that have been 
postulated as reasons for these early crestal bony changes, the establishment of an implant 
“biologic width” is one hypothesis that implicates peri-implant soft-tissue changes 
(Abrahamsson et al., 1996; Berglundh et al., 1996). Thus, the one-stage implant protocol 
used in this study could collaborate with the bone changes seen at implant loading. Bone 
resorption was similar in all groups, independent of periodontal history. After implant 
insertion, alveolar crest alterations were 0.77 ± 1.32 mm, 0.80 ± 0.94, and 1.14 ± 1.11 in 
the HGAgP, HGCP, and HH groups after 6 months of implant loading, and no difference 
was observed among groups. These changes in alveolar bone were in agreement with 
reports from other studies (Mengel & Flores-de-Jacoby, 2005; Mengel et al., 2007; Mengel 
et al., 2007; Al-Juboori et al., 2013; Yaghobee et al., 2013). Al-Juboori et al. (2013) found 
0.98 ± 0.56 mm crestal bone loss in Straumann Standard Implants 12 weeks after implant 
insertion. Mengel and Flores-de-Jacoby (2005) found 1.14 mm of bone loss in patients with 
aggressive periodontitis, 0.86 mm in patients with chronic periodontitis, and 0.70 mm in 
periodontally healthy patients after 3 years of loading. Mengel et al. (2007) reported 1.29 
mm of bone marginal bone loss in GAP patients and 0.71 mm in healthy patients after 3 
years. In a ten-year evaluation, Mengel et al. (2007) reported 2.07 mm of marginal bone 
loss in the first year of function in GAP patients, and 1.13 mm in healthy patients. 
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Yaghobee et al. (2013) reported bone loss of 1.66 ± 1.06 mm in healthy patients, after 3 
years of loading with Straumann implants.  
The pathogens Aggregatibacter actinomycetemcomitans, Porphyromonas 
gingivalis, Prevotella intermedia, Treponema denticola, and Tannerella forsythia were 
detected in healthy and diseased implants (Casado et al., 2011; Cortelli et al., 2013), and it 
was demonstrated that, even after tooth loss, key periodontal pathogens remain, colonizing 
the oral cavity (Fernandes et al., 2010). Thus, it has been suggested that the bacteria which 
cause periodontal breakdown could migrate and colonize peri-implant sites (Quirynen et 
al., 2005). The mere presence of Pi, Pg, and Aa was correlated with higher probing depths, 
increased bleeding, and a higher gingival sulcus fluid rate (George et al., 1994), but Casado 
et al. (2011) indicated that the presence of these periodontal pathogens in peri-implant sulci 
does not necessarily lead to destruction or even inflammatory symptoms, but, rather, that a 
combination of factors, including genetics, inflammatory response, and occlusal overload, 
may be involved.  
The present study investigated the presence of three periodontal pathogens and 
showed that Aa, Pg, and Tf were present around dental implants inserted into healthy 
periodontal patients and in patients presenting a history of periodontal disease. Differences 
among groups were observed at the 1st month after implant loading, when the Aa 
concentration was higher in the HGAgP group, and at 6 months after implant loading, when 
the Pg concentration was lower in the HH group.  
Studies reported in the literature have shown higher Aa levels in patients with 
aggressive than in those with chronic periodontitis (Schacher et al., 2007; Casarin et al., 
2010), which explains the difference among groups found at 1 month after implant loading.  
Regarding the Pg levels found in this study, the literature has reported a higher prevalence 
of Pg in those with chronic periodontitis than in periodontally healthy individuals (Cortelli 
et al., 2013), as well as higher Pg levels in patients with aggressive periodontitis (Casarin et 
al., 2010), so the higher levels of this bacterium in periodontitis groups at 6 months after 
implant loading is justified. In spite of this, no clinical or radiographic differences were 
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observed among groups, but it is important to note that the frequency of implants 
presenting BOP was elevated. A long-term follow-up should be done to investigate the 
consequences of microbiological presence, and other biofilm bacteria should be 
investigated to confirm the absence of differences among groups.   
In terms of immunologic parameters, studies have suggested that peri-implant 
gingiva may be characterized by a higher pro-inflammatory state under apparent 
homeostatic conditions (clinically healthy tissues) (Nowzari et al., 2008), and cytokines 
such as IL-1β, TNFα, and IL-8 can be predictors of peri-implant destruction (Petkovic et 
al., 2010). Thus, the analysis of inflammatory factors is important, considering that a 
history of periodontitis is associated with peri-implant diseases, and an imbalance between 
pro- and anti-inflammatory cytokines in aggressive periodontitis has been suggested (Teles 
et al., 2010). 
The present study shows intergroup differences only for interleukin-4 (IL-4) 
levels. Those in the HH group presented higher values of IL-4 than did those in the HGCP 
and HGAgP groups at 6 months after loading. IL-4, like interleukin-10 (IL-10), is an anti-
inflammatory Th2 cytokine that inhibits disease progression in inflammation sites and has a 
fundamental role in mediating bone resorption (Ebersole et al., 1994). The IL-4 levels of 
those in the HGAgP and HGCP groups were similar to those found by Fonseca et al. (2012) 
in peri-implantitis deep-pocket sites. IL-10 levels did not differ among groups and did not 
present intragroup alterations, but the levels observed in this study were similar to those 
found by Fonseca et al. (2012) in mucositis sites. 
Interestingly, interleukin-1beta (IL-1β) levels did not differ among groups.  IL-
1β is a pro-inflammatory polypeptide implicated in a wide range of biological processes, 
including inflammation, tissue breakdown, and tissue homeostasis (Tatakis et al., 1993; 
Ataoglu et al., 2002). Teles et al. (2010) suggested an imbalance between pro- and anti-
inflammatory cytokines in aggressive periodontitis. Based on this, high levels of IL-1β 
were expected in this group compared with the HGCP and HH groups, but this did not 
occur. In spite of that, the level of IL-1β found in this study was greater than that found by 
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Fonseca et al. (2012) in peri-implantitis sites in healthy patients. Other pro-inflammatory 
cytokines also presented alterations.  
Tumor necrosis factor alpha (TNFα) is a cytokine with a tendency to increase 
during the follow-up period. Even though no differences among groups were found, the 
values observed at the 6-month evaluation after implant loading were greater than those 
found previously. TNFα is a pro-inflammatory cytokine with the same function as IL-1β 
(Ataoglu et al., 2002), so its increase represents a risk for tissue breakdown due to 
osteoclastogenesis.   
Other cytokines presenting time-related alterations included interleukin-6 (IL-
6). In the HGAgP group, a significant increase was observed at implant loading, but this 
level returned to initial values after surgery. Interleukin-8, a potent chemotactic agent for 
neutrophils (Okada et al., 1998), presented high levels of expression in all groups. Although 
no differences among groups could be obtained, these values were higher than those 
reported by Fonseca et al. (2012) in mucositis sites, and were close to those reported by 
Petkovic et al. (2010) in early peri-implantitis sites, demonstrating a high concentration of 
pro-inflammatory factors.   
The present study also investigated the osteogenic markers OPG and RANKL. 
RANKL (osteoclast differentiation factor) binds directly to RANK on the surfaces of pre-
osteoclasts and osteoclasts, stimulating both the differentiation of osteoclast progenitors 
and the activity of mature osteoclasts (Lacey et al., 1998). Conversely, OPG, also known as 
osteoclastogenesis inhibitory factor, is a soluble circulating decoy receptor of RANKL that 
antagonizes the RANK-RANKL interaction and, therefore, promotes bone formation by 
inhibiting osteoclastogenesis (Bartold et al., 2010). 
In this study, the OPG levels in those in the HH group increased after implant 
surgery, and greater levels of this protein were obtained at implant loading in those in the 
HH group, but this difference was not found 6 months after loading. OPG levels at implant 
loading and 6 months later, in all groups (HGAgP, 19.70 ± 8.9 and 22.2 ± 23.9 pg/mL; 
HGCP, 20.1 ± 10.8 and 12.8 ± 14.8 pg/mL; HH, 40.5 ± 10.0 and 42.2 ± 19.9 pg/mL), were 
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similar to those found by Rakic et al. (2012) in healthy (15.92 ± 8.98 pg/mL) and diseased 
implant sites (18.99 ± 9.96 pg/mL) with 2 years of function.    
RANKL levels did not differ among groups, but in the HGAgP group, a 
statistically significant reduction in RANKL levels was observed after implant loading. In 
this group, a coincidence can be noted between the increased RANKL level and the point of 
greater bone alteration (0.54 ± 0.88 mm), but no additional bone loss was observed. 
The results presented in this study must be carefully evaluated, since they 
explain only 6 months of follow-up evaluation. Until now, the results corroborated those of 
Kim & Sung (2012), that implant treatment in patients presenting a history of generalized 
aggressive periodontitis is not contraindicated, since adequate infection control and an 
individualized maintenance program can be ensured. Nevertheless, patients with 
generalized aggressive periodontitis are susceptible to inflammation, and dental implant 
rehabilitation is a challenge requiring longitudinal studies to confirm the results presented 
here.    
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7 CONCLUSION/CONCLUSÃO 
 
Within the limitations of this study, it can be concluded that, 6 months after 
implant loading, Pg levels are greater in periodontitis patients, and IL-4 levels are greater in 
periodontally healthy individuals, but these conditions do not reflect clinical differences or 
additional bone resorption around implants placed in patients presenting a history of 
periodontal disease after a follow-up of 6 months. 
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